Wells Fargo & Company Actinium Pharmaceuticals, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Actinium Pharmaceuticals, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 14,559 shares of ATNM stock, worth $17,470. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,559

Previous 14,924 2.45%

Holding current value

$17,470

Previous $110,000 75.45%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$1.72 - $8.0 $627 - $2,920	-365 Reduced 2.45%	14,559 $27,000
Q2 2024 Aug 13, 2024	BUY	$6.56 - $9.89 $8,245 - $12,431	1,257 Added 9.2%	14,924 $110,000
Q1 2024 May 10, 2024	BUY	$5.0 - $9.2 $6,120 - $11,260	1,224 Added 9.84%	13,667 $107,000
Q4 2023 Feb 09, 2024	BUY	$4.02 - $6.08 $6,978 - $10,554	1,736 Added 16.21%	12,443 $63,000
Q3 2023 Nov 13, 2023	SELL	$5.91 - $7.37 $31,878 - $39,753	-5,394 Reduced 33.5%	10,707 $63,000
Q2 2023 Aug 15, 2023	BUY	$7.15 - $9.39 $75,968 - $99,768	10,625 Added 194.03%	16,101 $119,000
Q1 2023 May 12, 2023	BUY	$8.51 - $14.26 $34 - $57	4 Added 0.07%	5,476 $51,000
Q4 2022 Feb 13, 2023	BUY	$7.05 - $14.41 $2,855 - $5,836	405 Added 7.99%	5,472 $58,000
Q3 2022 Nov 14, 2022	BUY	$4.81 - $8.48 $38 - $67	8 Added 0.16%	5,067 $37,000
Q2 2022 Aug 12, 2022	BUY	$4.71 - $7.11 $108 - $163	23 Added 0.46%	5,059 $25,000
Q1 2022 May 16, 2022	BUY	$4.57 - $6.4 $4 - $6	1 Added 0.02%	5,036 $26,000
Q4 2021 Feb 14, 2022	SELL	$6.01 - $8.8 $2,854 - $4,180	-475 Reduced 8.62%	5,035 $30,000
Q3 2021 Nov 15, 2021	BUY	$5.76 - $9.67 $22,815 - $38,302	3,961 Added 255.71%	5,510 $49,000
Q2 2021 Aug 16, 2021	BUY	$7.01 - $8.63 $1,226 - $1,510	175 Added 12.74%	1,549 $12,000
Q1 2021 May 13, 2021	SELL	$7.62 - $9.79 $121,965 - $156,698	-16,006 Reduced 92.09%	1,374 $11,000
Q4 2020 Feb 09, 2021	BUY	$7.8 - $12.64 $131,125 - $212,491	16,811 Added 2954.48%	17,380 $136,000
Q3 2020 Nov 05, 2020	BUY	$7.26 - $18.0 $4,130 - $10,242	569 New	569 $6,000

Others Institutions Holding ATNM

# of Institutions

Shares Held

8.42M

Call Options Held

65.2K

Put Options Held

21.7K

View Full List

About Actinium Pharmaceuticals, Inc.

Ticker ATNM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,184,700
Market Cap $30.2M
Description
Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...

More about ATNM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Actinium Pharmaceuticals, Inc. Transaction History